sorin Intensia SonR CRT-D 184, Руководство по имплантации, Страница: 6 / 68

15.2. Magnet mode..........................................................................................................................37
15.3. Response in the presence of interference..............................................................................37
15.4. Detection characteristics in the presence of electromagnetic fields........................................38
15.5. Protection against short-circuits..............................................................................................38
16. Main functions.......................................................................................................................39
16.1. Automatic lead measurements................................................................................................39
16.2. Atrial tachyarrhythmia management.......................................................................................39
16.3. Ventricular tachyarrhythmia management...............................................................................39
16.4. Pacing..................................................................................................................................... 39
16.5. Sensing................................................................................................................................... 40
16.6. SonR CRT optimization...........................................................................................................40
16.7. Follow-up function...................................................................................................................41
16.8. Remote Monitoring function....................................................................................................41
17. Patient follow-up...................................................................................................................43
17.1. Follow-up recommendations...................................................................................................43
17.2. Holter Function........................................................................................................................43
17.3. Recommended Replacement Time (RRT)..............................................................................44
17.4. Explantation............................................................................................................................44
17.5. Defibrillator identification.........................................................................................................45
18. Supplemental Information....................................................................................................46
18.1. Adverse events in the SafeR (AAI <> DDD) study..................................................................46
18.2. SafeR (AAI <> DDD) clinical study..........................................................................................47
19. Physical characteristics.......................................................................................................49
19.1. Materials used.........................................................................................................................49
20. Electrical characteristics......................................................................................................50
20.1. Table of delivered shock energy and voltage..........................................................................50
20.2. Battery..................................................................................................................................... 50
20.3. Longevity................................................................................................................................. 51
21. Programmable parameters...................................................................................................52
21.1. Antibradycardia pacing............................................................................................................52
21.2. Ventricular tachyarrhythmia detection.....................................................................................55
21.3. Ventricular tachyarrhythmia therapies.....................................................................................56
21.4. Remote alerts and warnings...................................................................................................59
22. Non programmable parameters...........................................................................................61
23. Limited warranty...................................................................................................................62
23.1. Article 1 : Terms of limited warranty........................................................................................62
23.2. Article 2 : Terms of replacement..............................................................................................63
24. Patents................................................................................................................................... 64
25. Explanation of symbols........................................................................................................65
4 SORIN – INTENSIA SonR CRT-D 184 – U150A